Cited by 365Cardiomyopathy and Myosin StudiesCardiovascular Syncope and Autonomic DisordersCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

Open access

Spirito, Paolo, Autore, Camillo, Rapezzi, Claudio, Bernabò, Paola, Badagliacca, Roberto, Maron, Martin S., Bongioanni, Sergio, Coccolo, Fabio, Estes, N.A. Mark, Barillà, Caterina S., Biagini, Elena, Quarta, Giovanni, Conte, Maria Rosa, Bruzzi, Paolo, Maron, Barry J.·2009·Circulation

DOI 10.1161/circulationaha.108.798314

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The prognostic significance of syncope has not been investigated systematically in hypertrophic cardiomyopathy, and treatment strategies have been based largely on intuition and experience. METHODS AND RESULTS: We assessed the relationship between syncope and sudden death in 1511 consecutive patients with hypertrophic cardiomyopathy. Unexplained (n=153) or neurally mediated (n=52) syncope occurred in 205 patients (14%). Over a 5.6+/-5.2-year follow-up, 74 patients died suddenly. Relative risk of sudden death was 1.78 (95% confidence interval 0.88 to 3.51, P=0.08) in patients with unexplained syncope and 0.91 (95% confidence interval 0.00 to 3.83, P=1.0) in those with neurally mediated syncope compared with patients without syncope. In multivariable analysis, the temporal proximity of unexplained syncope to initial patient evaluation was independently associated with risk of sudden death (P=0.006). Patients with unexplained syncope within 6 months before the initial evaluation showed a 5-fold increase in risk compared with patients without syncope (adjusted hazard ratio 4.89, 95% confidence interval 2.19 to 10.94), a relationship that was maintained throughout all age groups (<18, 18 to 39, and > or =40 years). Older patients (> or =40 years of age) with remote episodes of syncope (>5 years before initial evaluation) did not show an increased risk of sudden death (adjusted hazard ratio 0.38, 95% confidence interval 0.05 to 2.74). CONCLUSIONS: In the present large cohort of patients with hypertrophic cardiomyopathy, unexplained syncope was a risk factor for sudden death. Patients with syncopal events that occurred in close temporal proximity to the initial evaluation showed a substantially higher risk of sudden death than patients without syncope. Older patients with remote syncopal events did not show an increased risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.798314

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Self-citation
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Incidence and Prognosis of Syncope
Soteriades, E. S., Evans, J. C., Larson, M. G., Chen, M. H., Chen, L., Benjamin, E. J., & Levy, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012407 · Cited by 1,364
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,026
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. G. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 898
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802

Flagged first, then by citations

Show all 30 references

Research works printed but not linked: 1

10.1161/circ.85.6.1591832 · DOI

Sorted by citations

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Heart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,264
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
Deakin, C. D., Nolan, J. P., Soar, J., Sunde, K., Koster, R. W., Smith, G. B., & Perkins, G. D. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.017 · Cited by 2,711
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), societies, E. B. T. F., European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp298 · Cited by 2,040
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,902
Hypertrophic Cardiomyopathy
Hypertensive, Y., & Chin, K. (1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,757
European Resuscitation Council Guidelines for Resuscitation 2015
Soar, J., Nolan, J. P., Böttiger, B. W., Perkins, G. D., Lott, C., Carli, P. A., Pellis, T., Sandroni, C., Skrifvars, M. B., Smith, G. B., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.016 · Cited by 1,498
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
European Resuscitation Council Guidelines for Resuscitation 2015
Perkins, G. D., Handley, A. J., Koster, R. W., Castrén, M. K., Smyth, M. A., Olasveengen, T. M., Monsieurs, K. G., Raffay, V. I., Gräsner, J., Wenzel, V., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.015 · Cited by 1,339
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Self-citation
European Resuscitation Council Guidelines 2021: Adult advanced life support
Soar, J., Böttiger, B. W., Carli, P. A., Couper, K., Deakin, C. D., Djärv, T., Lott, C., Olasveengen, T. M., Paal, P., Pellis, T., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.010 · Cited by 1,255
Hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 997
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 825
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 771
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 743
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Part 1: Executive summary
Nolan, J. P., Hazinski, M. F., Billi, J. E., Boettiger, B. W., Bossaert, L. L., de Caen, A. R., Deakin, C. D., Drajer, S., Eigel, B. N., Hickey, R. W., et al. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.002 · Cited by 700
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 689
Hypertrophic Cardiomyopathy
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
Self-citation
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 644
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000937 · Cited by 641
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya‐Mitjans, À., de Lange, F. J., Deharo, J., Elliot, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martiın, A., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0161 · Cited by 475
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K., Evanovich, L., Ferrari, V. A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.014 · Cited by 425
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0212 · Cited by 342
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000938 · Cited by 336
Self-citation
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., Wessler, B. S., Mooney, P., Fatima, A., Patel, P. P., Koethe, B. C., Romashko, M. D., Link, M. S., & Maron, B. J. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1391 · Cited by 323
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 326
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia
Corrado, D., Calkins, H., Link, M. S., Leoni, L., Favale, S., Bevilacqua, M., Basso, C., Ward, D., Boriani, G., Ricci, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.913871 · Cited by 306
Self-citation
Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J. (2010) · Circulation · doi:10.1161/circulationaha.109.878579 · Cited by 298
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Ackerman, M. J., Casey, S. A., Semsarian, C., Estes, N. A. M., Shannon, K. M., Ashley, E. A., Day, S. M., Pacileo, G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.037 · Cited by 288
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.825 · Cited by 279
Part 12: Education, implementation, and teams
Soar, J., Mancini, M. E., Bhanji, F., Billi, J. E., Dennett, J., Finn, J., Huei‐Ming, M., Perkins, G. D., Rodgers, D. L., Hazinski, M. F., et al. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.030 · Cited by 282
Guía de práctica clínica para el diagnóstico y manejo del síncope (versión 2009)
Moya‐Mitjans, À., Sutton, R., Ammirati, F., Blanc, J., Brignole, M., Dahm, J. B., Deharo, J., Gajek, J. J., Gjesdal, K., Krahn, A. D., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73541-8 · Cited by 277
Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age
Maron, B. J., Rowin, E. J., Casey, S. A., Haas, T. S., Chan, R. H. M., Udelson, J. E., Garberich, R. F., Lesser, J. R., Appelbaum, E., Manning, W. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.136085 · Cited by 224
Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography
Nagueh, S. F., Phelan, D. M. J., Abraham, T. P., Armour, A. C., Desai, M. Y., Dragulescu, A., Gilliland, Y. E., Lester, S. J., Maldonado, Y., MOHIDDIN, S. A., et al. (2022) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.03.012 · Cited by 216
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0637 · Cited by 205
Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy
Maron, B. J., Casey, S. A., Chan, R. H. M., Garberich, R., Rowin, E. J., & Maron, M. S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.05.047 · Cited by 181
Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Maron, B. J., Rowin, E. J., Casey, S. A., Lesser, J. R., Garberich, R., McGriff, D. M., & Maron, M. S. (2015) · Circulation · doi:10.1161/circulationaha.115.017633 · Cited by 172
JCS/JHRS 2019 guideline on non‐pharmacotherapy of cardiac arrhythmias
Nogami, A., Kurita, T., Abe, H., Andò, K., Ishikawa, T., Imai, K., Usui, A., Okishige, K., Kusano, K., Kumagai, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12491 · Cited by 166
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
D, E. B. M., Saberi, S., Abraham, T. P., Elliot, P. M., & Olivotto, I. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad637 · Cited by 161
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
O’Mahony, C., Tome, M., Lambiase, P. D., Pantazis, A. A., Dickie, S., McKenna, W. J., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303271 · Cited by 159
Sudden Cardiac Death
Kuriachan, V. P., Sumner, G., & Mitchell, L. B. (2015) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.01.002 · Cited by 166
European Resuscitation Council Guidelines 2025 Adult Advanced Life Support
Soar, J., Böttiger, B. W., Carli, P. A., Carmona, F., Cimpoesu, D. C., Cole, G., Couper, K., D’Arrigo, S., Deakin, C. D., Ek, J. E., et al. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110769 · Cited by 192
Pharmacological Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives
Ammirati, E., Contri, R., Coppini, R., Cecchi, F., Frigerio, M., & Olivotto, I. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.541 · Cited by 148
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy
Lampert, R., Ackerman, M. J., Marino, B. S., Burg, M., Ainsworth, B., Salberg, L., Tome Esteban, M. T., Ho, C. Y., Abraham, R., Balaji, S., et al. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.1042 · Cited by 148
Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Vriesendorp, P. A., Schinkel, A. F. L., Liebregts, M., Theuns, D. A. M. J., Cleemput, J. V., ten Cate, F. J., Willems, R., & Michels, M. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002553 · Cited by 141
Hypertrophic cardiomyopathy: genetics and clinical perspectives
Wolf, C. M. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.02.01 · Cited by 139
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life‐Threatening Arrhythmias
Spezzacatene, A., Sinagra, G., Merlo, M., Barbati, G., Graw, S. L., Brun, F., Slavov, D. B., Lenarda, A. D., Salcedo, E. E., Towbin, J. A., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002149 · Cited by 138
Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors
Spirito, P., Autore, C., Formisano, F., Assenza, G. E., Biagini, E., Haas, T. S., Bongioanni, S., Semsarian, C., Devoto, E., Musumeci, B., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.435 · Cited by 131
Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population
Lorenzini, M., Anastasiou, Z., O’Mahony, C., Guttmann, O. P., Gimeno, J. R., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., García‐Pavía, P., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4534 · Cited by 127
Hypertrophic Cardiomyopathy
Hensley, N. B., Dietrich, J., Nyhan, D. P., Mitter, N., Yee, M.-S., & Brady, M. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000538 · Cited by 123
Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy
Bos, J. M., Maron, B. J., Ackerman, M. J., Haas, T. S., Sorajja, P., Nishimura, R. A., Gersh, B. J., & Ommen, S. R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.077 · Cited by 102
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
Biagini, E., Spirito, P., Rocchi, G., Ferlito, M., Rosmini, S., Lai, F., Lorenzini, M., Terzi, F., Reggiani, M. L. B., Boriani, G., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.057 · Cited by 115
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy
Johnson, J. N., Grifoni, C., Bos, J. M., Saber-Ayad, M. M., Ommen, S. R., Nistri, S., Cecchi, F., Olivotto, I., & Ackerman, M. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr021 · Cited by 111
Pediatric Cardiomyopathies: causes, epidemiology, Clinical course, Preventive Strategies and Therapies
Lipshultz, S. E., Cochran, T. R., Briston, D. A., Brown, S. R., Sambatakos, P., Miller, T. L., Carrillo, A. A., Corcia, L., Sanchez, J. E., Diamond, M. B., et al. (2013) · Future Cardiology · doi:10.2217/fca.13.66 · Cited by 117
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
Iacovoni, A., Spirito, P., Simon, C., Iascone, M. R., Dedda, G. D., Filippo, P. D., Pentiricci, S., Boni, L., Senni, M., Gavazzi, A., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs064 · Cited by 109
Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile
Jensen, M. K., Prinz, C., Horstkotte, D., van Buuren, F., Bitter, T., Faber, L., & Bundgaard, H. (2013) · Heart · doi:10.1136/heartjnl-2012-303339 · Cited by 108
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
O’Mahony, C., Elliot, P. M., & McKenna, W. J. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962043 · Cited by 106
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.001 · Cited by 92
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
Maron, B. J., Rowin, E. J., & Maron, M. S. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.01.019 · Cited by 89
Part 12: Education, Implementation, and Teams
Mancini, M. E., Soar, J., Bhanji, F., Billi, J. E., Dennett, J., Finn, J., Huei‐Ming, M., Perkins, G. D., Rodgers, D. L., Hazinski, M. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971143 · Cited by 92
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.019 · Cited by 85
Risk Stratification and Role of Implantable Defibrillators for Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy
Maron, B. J. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0921 · Cited by 84
Formin Homology 2 Domain Containing 3 Variants Associated With Hypertrophic Cardiomyopathy
Wooten, E. C., Hebl, V. B., Wolf, M. J., Greytak, S. R., Orr, N. M., Draper, I., Calvino, J. E., Kapur, N. K., Maron, M. S., Kullo, I. J., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.965277 · Cited by 79
Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy
Hinojar, R., Zamorano, J. L., Fernández-Méndez, M. Á., Esteban, A., Martín, M. P., González-Gómez, A., Carbonell, A., Rincon, L. M., Nácher, J. J. J., & Fernández‐Golfín, C. (2019) · International journal of cardiac imaging · doi:10.1007/s10554-019-01534-8 · Cited by 79
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.048 · Cited by 74
Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention
Koene, R. J., Adkisson, W. O., & Benditt, D. G. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.07.005 · Cited by 77
Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy
on behalf of Italian Chapter of, I. S. C. U., Parato, V. M., Antoncecchi, V., Sozzi, F. B., Marazìa, S., Zito, A., Maiello, M. R., & Palmiero, P. (2015) · Cardiovascular Ultrasound · doi:10.1186/s12947-016-0072-5 · Cited by 72
Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy
Liu, H., Pozios, I., Haileselassie, B., Nowbar, A. N., Sorensen, L. L., Phillip, S., Lu, D., Ventoulis, I., Luo, H., Abraham, M. R., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.039 · Cited by 71
Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis
Pelliccia, F., Pasceri, V., Limongelli, G., Autore, C., Basso, C., Corrado, D., Imazio, M., Rapezzi, C., Sinagra, G., & Mercuro, G. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.071 · Cited by 66
Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up
Dimitrow, P. P., Chojnowska, L., Rudziński, T., Piotrowski, W., Ziółkowska, L., Wojtarowicz, A., Wycisk, A., Dąbrowska-Kugacka, A., Nowalany-Kozielska, E., Sobkowicz, B., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq308 · Cited by 69
Myocardial Fibrosis Severity on Cardiac Magnetic Resonance Imaging Predicts Sustained Arrhythmic Events in Hypertrophic Cardiomyopathy
Prinz, C., Schwarz, M., Ilić, I., Laser, K. T., Lehmann, R., Prinz, E., Bitter, T., Vogt, J., van Buuren, F., Bogunović, N., et al. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.05.004 · Cited by 68
Hypertrophic Cardiomyopathy in Childhood
Colan, S. D. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.05.004 · Cited by 68
Prodromal symptoms of out-of-hospital cardiac arrests: A report from a large-scale population-based cohort study
Nishiyama, C., Iwami, T., Kawamura, T., Kitamura, T., Tanigawa, K., Sakai, T., Hayashida, S., Nishiuchi, T., Hayashi, Y., & Hiraide, A. (2012) · Resuscitation · doi:10.1016/j.resuscitation.2012.10.006 · Cited by 68
Erweiterte lebensrettende Maßnahmen für Erwachsene
Soar, J., Böttiger, B. W., Carli, P. A., Couper, K., Deakin, C. D., Djärv, T., Lott, C., Olasveengen, T. M., Paal, P., Pellis, T., et al. (2021) · Notfall + Rettungsmedizin · doi:10.1007/s10049-021-00893-x · Cited by 68
Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis
Liu, Q., Li, D., Berger, A. E., Johns, R. A., & Gao, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-12289-4 · Cited by 66
Tissue Doppler Imaging and Plasma BNP Levels to Assess the Prognosis in Patients with Hypertrophic Cardiomyopathy
Kitaoka, H., Kubo, T., Okawa, M., Takenaka, N., Sakamoto, C., Baba, Y., Hayashi, K., Yamasaki, N., Matsumura, Y., & Doi, Y. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.05.009 · Cited by 62
Erweiterte Reanimationsmaßnahmen für Erwachsene („adult advanced life support“)
Soar, J., Nolan, J. P., Böttiger, B. W., Perkins, G. D., Lott, C., Carli, P. A., Pellis, T., Sandroni, C., Skrifvars, M. B., Smith, G. B., et al. (2015) · Notfall + Rettungsmedizin · doi:10.1007/s10049-015-0085-x · Cited by 59
Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge
Weissler‐Snir, A., Adler, A., Williams, L. K., Gruner, C., & Rakowski, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw268 · Cited by 59
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy
Kłopotowski, M. M., Kukuła, K., Małek, Ł. A., Śpiewak, M., Polańska-Skrzypczyk, M., Jamiołkowski, J., Dąbrowski, M., Baranowski, R., Klisiewicz, A., Kuśmierczyk, M., et al. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.07.020 · Cited by 55
Hypertrophic cardiomyopathy
Antunes, M. D. O., & Scudeler, T. L. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100503 · Cited by 53
Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy
Leong, K. M. W., Chow, J., Ng, F. S., Falaschetti, E., Qureshi, N. A., Koa‐Wing, M., Linton, N. W. F., Whinnett, Z. I., Lefroy, D. C., Davies, D. W., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.10.027 · Cited by 48
Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification
Tower-Rader, A. F., Kramer, C. M., Neubauer, S., Nagueh, S. F., & Desai, M. Y. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.009026 · Cited by 47
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
Hong, Y., SU, W. W., & Li, X. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000939 · Cited by 46
Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9147-0 · Cited by 46
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment
Jacoby, D. L., DePasquale, E. C., & McKenna, W. J. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.120138 · Cited by 44
Erweiterte Reanimationsmaßnahmen für Erwachsene („advanced life support“)
Deakin, C. D., Nolan, J. P., Soar, J., Sunde, K., Koster, R. W., Smith, G. B., & Perkins, G. D. (2010) · Notfall + Rettungsmedizin · doi:10.1007/s10049-010-1370-3 · Cited by 45

Authors: Spirito, P., Autore, C., Rapezzi, C., Bernabò, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N. A. M., Barillà, C. S., Biagini, E., Quarta, G., Conte, M. R., Bruzzi, P., & Maron, B. J.
Affiliations: Tufts Medical Center (US)
From the Ente Ospedaliero Ospedali Galliera (P.S., P. Bernabò), Genoa, Italy; Università La Sapienza (C.A., R.B., C.S.B., G.Q.), Roma, Italy; Universitá di Bologna (C.R., F.C., E.B.), Bologna, Italy; Tufts-New England Medical Center (M.S.M., N.A.M.E.), Boston, Mass; Ospedale di Rivoli (S.B., M.R.C.), Torino, Italy; Istituto Nazionale per la Ricerca sul Cancro (P. Bruzzi), Genoa, Italy; and Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation (B.J.M.), Minneapolis, Minn.
ORCID: Spirito, Paolo
Autore, Camillo
Rapezzi, Claudio
Badagliacca, Roberto
Maron, Martin S.
Estes, N.A. Mark
Biagini, Elena
Bruzzi, Paolo
Maron, Barry J.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-04-07
Volume: 119
Issue: 13
Pages: 1703-1710
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.108.798314
OpenAlex: W2103423712
Cited by: 365
References: 30
Citations by year: 2026: 8 · 2025: 24 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 18 · 2020: 23 · 2019: 12 · 2018: 26 · 2017: 34 · 2016: 21 · 2015: 25 · 2014: 21 · 2013: 19 · 2012: 30
FWCI: 18.84
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by-nc-nd)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, syncope, sudden death, unexplained syncope, neurally mediated syncope, risk factors, prognosis, age-related risk
MeSH terms: Adolescent, Adult, Aged, Cardiomyopathy, Hypertrophic, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Risk Factors, Syncope, Multivariate Analysis, Proportional Hazards Models, Death, Sudden, Cardiac, Defibrillators, Implantable, Age Distribution, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks